112 related articles for article (PubMed ID: 2958051)
1. Radiologic observations in severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Mortensson W; Noack G; Curstedt T; Herin P; Robertson B
Acta Radiol; 1987; 28(4):389-94. PubMed ID: 2958051
[TBL] [Abstract][Full Text] [Related]
2. Severe neonatal respiratory distress syndrome treated with the isolated phospholipid fraction of natural surfactant.
Noack G; Berggren P; Curstedt T; Grossmann G; Herin P; Mortensson W; Nilsson R; Robertson B
Acta Paediatr Scand; 1987 Sep; 76(5):697-705. PubMed ID: 3661171
[TBL] [Abstract][Full Text] [Related]
3. Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Collaborative European Multicenter Study Group.
Pediatrics; 1988 Nov; 82(5):683-91. PubMed ID: 2903480
[TBL] [Abstract][Full Text] [Related]
4. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
[TBL] [Abstract][Full Text] [Related]
5. Randomized multicentre trial of treatment with porcine natural surfactant for moderately severe neonatal respiratory distress syndrome. The Collaborative European Multicentre Study Group.
Bevilacqua G; Halliday H; Parmigiani S; Robertson B
J Perinat Med; 1993; 21(5):329-40. PubMed ID: 8126628
[TBL] [Abstract][Full Text] [Related]
6. Surfactant replacement in the management of the neonatal respiratory distress syndrome.
Robertson B
Eur J Respir Dis Suppl; 1987; 153():242-8. PubMed ID: 3322864
[TBL] [Abstract][Full Text] [Related]
7. Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases.
Mazela J; Merritt TA; Gadzinowski J; Sinha S
Acta Paediatr; 2006 Sep; 95(9):1036-48. PubMed ID: 16938747
[TBL] [Abstract][Full Text] [Related]
8. Surfactant substitution in ventilated very low birth weight infants: factors related to response types.
Segerer H; Stevens P; Schadow B; Maier R; Kattner E; Schwarz H; Curstedt T; Robertson B; Obladen M
Pediatr Res; 1991 Dec; 30(6):591-6. PubMed ID: 1805156
[TBL] [Abstract][Full Text] [Related]
9. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
[TBL] [Abstract][Full Text] [Related]
10. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
11. Neonatal respiratory distress syndrome and surfactant therapy; a brief review.
Robertson B
Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999
[TBL] [Abstract][Full Text] [Related]
12. Radiological changes after therapeutic use of surfactant in infants with respiratory distress syndrome.
Dinger J; Schwarze R; Rupprecht E
Pediatr Radiol; 1997 Jan; 27(1):26-31. PubMed ID: 8995163
[TBL] [Abstract][Full Text] [Related]
13. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V
N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470
[TBL] [Abstract][Full Text] [Related]
14. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
Morley CJ
Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
[TBL] [Abstract][Full Text] [Related]
15. Respiratory distress syndrome treated with human surfactant: radiographic findings.
Edwards DK; Hilton SV; Merritt TA; Hallman M; Mannino F; Boynton BR
Radiology; 1985 Nov; 157(2):329-34. PubMed ID: 3840268
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of severe respiratory distress syndrome with surfactant].
Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
[TBL] [Abstract][Full Text] [Related]
17. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
[TBL] [Abstract][Full Text] [Related]
18. [Natural surfactant in routine treatment of neonatal respiratory distress syndrome. Experiences from two central hospitals].
Grønn M; Silberg IE
Tidsskr Nor Laegeforen; 1997 Apr; 117(10):1453-6. PubMed ID: 9198921
[TBL] [Abstract][Full Text] [Related]
19. Use of surfactant in pulmonary disorders in full-term infants.
Sun B
Curr Opin Pediatr; 1996 Apr; 8(2):113-7. PubMed ID: 8723804
[TBL] [Abstract][Full Text] [Related]
20. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]